Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron for anaemia in critically ill ICU patients
ACTRN12612001249842Phase 2Active, not recruiting
- Sponsor
- Edward Litton
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anaemia comparing Ferric carboxymaltose with Placebo saline (2 arms). Primary endpoint: Mean number of packed red blood cell units transfused from enrolment to hospital discharge. Started Jun 2013; status: active, not recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
anaemia
Beyond the preview
Go deeper on ACTRN12612001249842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001249842.